2 Followers on Owler

Amakem

Read more
Jack Elands's photo - CEO of Amakem

CEO

Jack Elands

CEO Approval Rating

68/100

Founded:

01/2010

Status:

PrivateIndependent Company

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Sector

Update Industry

Amakem Acquisitions

No recent acquisitions found related to Amakem

Amakem Funding History

Since Amakem was founded in 01/2010, it has participated in 1 round of funding. In total Amakem has raised $25.4M. Amakem's funding round was on Sep 2011 for a total of $25.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Sep 2011
$25.4M

Since Amakem was founded in 01/2010, it has participated in 1 round of funding. In total Amakem has raised $25.4M. Amakem's funding round was on Sep 2011 for a total of $25.4M

Amakem Investments

No recent investments found related to Amakem

Amakem News

Amakem Press Releases

June 24, 2015BUSINESS WIRE

Corneal Neovascularization Therapeutics Pipeline Review 2015 - 4 Companies & 10 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fmk9dw/corn... See more »
June 12, 2015BUSINESS WIRE

Ocular Hypertension - Pipeline Review, H1 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jrdqcj/ocul... See more »
May 14, 2015PR-INSIDE.COM

Rodos BioTarget GmbH - Product Pipeline Review - 2015

(PR-inside.com) Global Markets Direct's, 'Amakem NV - Product Pipeline Review - 2015', provides an ov... See more »
March 5, 2015BUSINESS WIRE

Open-Angle Glaucoma Pipeline Review 2015 Featuring 15 Leading Therapeutics Companies

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8m649s/open... See more »
January 2, 2015BUSINESS WIRE

Ocular Hypertension - Pipeline Review, H2 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wnlgv4/ocul... See more »
December 8, 2014BUSINESS WIRE

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/z99lbd/wet_... See more »
June 12, 2014BUSINESS WIRE

Corneal Neovascularization - Pipeline Review, H1 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sz87mj/corn... See more »

Social Media

Amakem Headquarters

Amakem NV BioVille Agoralaan bldg

Diepenbeek, Limburg3590

321-128-6982

Driving Directions »

Trending Companies

Amakem Summary

ABOUT

Overview

Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem was founded in 01/2010. Amakem's headquarters is located in Diepenbeek, Limburg, BE 3590. It has raised 25.4M in 1 round....

CEO

Amakem's CEO, Jack Elands, currently has an approval rating of 68%. Amakem's primary competitors are

Website

amakem.com

Frequently Asked Questions about Amakem

  1. When was Amakem founded?

    Amakem was founded in 01/2010
  2. Who is Amakem's CEO?

    Amakem's CEO is Jack Elands
  3. How much revenue does Amakem generate?

    Amakem generates $ < 1M in revenue
  1. How much funding does Amakem have?

    Amakem has historically raised $25.4M in funding
  2. Where is Amakem's headquarters?

    Amakem's headquarters is in Diepenbeek Limburg, BE
  3. How many employees does Amakem have?

    Amakem has 0 employees